Use of A2A adenosine receptor agonists

Details for Australian Patent Application No. 2005295437 (hide)

International Classifications

Event Publications

10 May 2007 PCT application entered the National Phase

PCT publication WO2006/044856 Priority application(s): WO2006/044856

10 May 2007 Change of Name(s) of Applicant(s), Section 104

CV Therapeuitics, Inc. The name of the applicant has been changed to CV Therapeutics, Inc.

22 October 2009 Alteration of Name

The name of the applicant has been altered to Gilead Palo Alto, Inc. Amendments

19 May 2011 Application Accepted

Published as AU-B-2005295437

15 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.